Preparation of antioxidant-biodegradable poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogel using rutin as a crosslinker: Drug release and anticancer activity
dc.authorid | Comert Onder, Ferah/0000-0002-4037-1979 | |
dc.authorid | Ozay, Hava/0000-0002-4184-7801 | |
dc.contributor.author | Onder, Ferah Comert | |
dc.contributor.author | Onder, Alper | |
dc.contributor.author | Ilgin, Pinar | |
dc.contributor.author | Ozay, Hava | |
dc.contributor.author | Özay, Özgür | |
dc.date.accessioned | 2025-01-27T20:17:11Z | |
dc.date.available | 2025-01-27T20:17:11Z | |
dc.date.issued | 2023 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | It is important to develop drug-release systems that reduce the side effects of chemotherapy drugs, can regulate drug release, and can be designed for a target to keep the quality of life of cancer patients high. In this study, a polyphenol compound rutin was used as a natural crosslinker to prepare poly(acrylic acid-co-2-hydroxyethyl methacrylate)/rutin (RTN hydrogel) as a drug carrier. The swelling behavior, thermal stability, in vitro biode-gradability, and antioxidant activity of this hydrogel were determined. The prepared hydrogel had in vitro biodegradability and antioxidant properties. The maximum doxorubicin (DOX) amount adsorbed by the RTN hydrogel was 32.96 & PLUSMN; 1.83 mg/g. The DOX-loaded RTN hydrogel displayed drug release behavior in normal and cancer cell media. At the same time, the effect of the DOX-loaded hydrogel on triple negative breast cancer (TNBC) cell lines was investigated. Our results show that the RTN hydrogel, prepared using the natural product of rutin as a crosslinker with in vitro biodegradability and antioxidant properties, offers great promise as a high-impact carrier in the drug distribution system. | |
dc.identifier.doi | 10.1016/j.reactfunctpolym.2023.105650 | |
dc.identifier.issn | 1381-5148 | |
dc.identifier.issn | 1873-166X | |
dc.identifier.scopus | 2-s2.0-85162220225 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.uri | https://doi.org/10.1016/j.reactfunctpolym.2023.105650 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/21510 | |
dc.identifier.volume | 190 | |
dc.identifier.wos | WOS:001031596500001 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.ispartof | Reactive & Functional Polymers | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Cancer | |
dc.subject | Biomaterial | |
dc.subject | Hydrogel | |
dc.subject | Biodegradable | |
dc.subject | Drug delivery | |
dc.title | Preparation of antioxidant-biodegradable poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogel using rutin as a crosslinker: Drug release and anticancer activity | |
dc.type | Article |